Skip to main content Skip to section navigation Skip to footer
Avalon GloboCare Corp.
  • Home
  • About
    • Overview
    • Executive Team
    • Board of Directors
  • Agentic AI
  • Consumer Health
  • Investors
    • Overview
    • News & Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Information
    • Overview
    • Executive Team
    • Contacts
    • FAQ
  • Financial Information
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Corporate Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Jun 04, 2018 7:00am EDT

Avalon GloboCare Appoints Former Deputy Secretary of the U.S. Department of Health and Human Services Dr. Tevi Troy to its Board of Directors

May 14, 2018 8:00am EDT

Avalon GloboCare Provides First Quarter 2018 Business Update; Reports 365% Increase in Revenues and Progress Towards Commercialization of its Cell-Based Technologies

Apr 24, 2018 7:30am EDT

Avalon GloboCare Forms Joint Laboratory with Top-Ranked Hospital in Shanghai for Regenerative Exosomics

Mar 19, 2018 8:00am EDT

Avalon GloboCare Submits Listing Application for The NASDAQ Capital Market

Mar 13, 2018 7:30am EDT

Avalon GloboCare Reports 75% Increase in Revenue for the Year Ended 2017

Feb 28, 2018 7:30am EST

Avalon GloboCare Teams up with Weill Cornell Medicine to Establish Joint Translational Research Initiative in Stem Cell Technology and Regenerative Medicine

Feb 14, 2018 8:00am EST

Avalon GloboCare Subsidiary GenExosome Expands Operations into the United States

Jan 30, 2018 8:00am EST

Avalon GloboCare Forms Strategic Partnership with Major Biomedical Enterprise Da An Gene

Jan 21, 2018 8:20am EST

Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the "China's Impact on The World of Regenerative Medicine" Session at the 13th Annual World Stem Cell Summit

Jan 16, 2018 8:00am EST

Avalon GloboCare Appoints Dr. Bo Chen as Vice President of Mergers & Acquisitions to Accelerate Growth

  • Previous Pagearrow_back
  • Page 1…
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
©2026 Avalon GloboCare Corp. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences